Harm Westdorp
Impact in
- Immunology top 5%
- Immunotherapy and Immune Responses
- Oncology top 10%
- Cancer Immunotherapy and Biomarkers
- Peptidase Inhibition and Analysis
- CAR-T cell therapy research
Papers in
- Immunology 14
- Immunotherapy and Immune Responses 13
- Oncology 11
- Cancer Immunotherapy and Biomarkers 8
- Cancer survivorship and care 1
- Pancreatic and Hepatic Oncology Research 1
- Co-authors
- I. Jolanda M. de Vries (17 shared papers)Gerty Schreibelt (13 shared papers)Winald R. Gerritsen (18 shared papers)Niven Mehra (12 shared papers)Sandra Heskamp (3 shared papers)Carl Gustav Figdor (10 shared papers)James Nagarajah (6 shared papers)Bastiaan M. Privé (5 shared papers)
- Journals
- Annals of Oncology (6 papers)Frontiers in Immunology (5 papers)Frontiers in Oncology (2 papers)Clinical Cancer Research (2 papers)OncoImmunology (2 papers)
- Partner nations
- NetherlandsGermanyUnited Kingdom
In The Last Decade
Harm Westdorp
47 papers receiving 1.2k citations
Harm Westdorp's Hit Papers
Peers
Comparison fields: 5 of 43
- Immunology 356
- Oncology 218
- Radiology, Nuclear Medicine and Imaging 150
- Ophthalmology 36
- Pulmonary and Respiratory Medicine 74
Countries citing papers authored by Harm Westdorp
This map shows the geographic impact of Harm Westdorp's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Harm Westdorp with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Harm Westdorp more than expected).
Fields of papers citing papers by Harm Westdorp
This network shows the impact of papers produced by Harm Westdorp. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Harm Westdorp. The network helps show where Harm Westdorp may publish in the future.
Co-authors
The 25 scholars most cited alongside Harm Westdorp, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 52 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2015 | 205 | |
| 2 | Fibroblast activation protein-targeted radionuclide therapy: background, opportunities, and challenges of first (pre)clinical studies Hit paper breakdown → | 2023 | 138 |
| 3 | 2019 | 99 | |
| 4 | 2014 | 76 | |
| 5 | 2016 | 75 | |
| 6 | 2022 | 57 | |
| 7 | 2020 | 52 | |
| 8 | 2017 | 49 | |
| 9 | 2016 | 43 | |
| 10 | 2021 | 37 | |
| 11 | 2018 | 34 | |
| 12 | 2021 | 32 | |
| 13 | 2016 | 31 | |
| 14 | 2021 | 26 | |
| 15 | 2024 | 26 | |
| 16 | 2018 | 23 | |
| 17 | 2023 | 23 | |
| 18 | 2016 | 22 | |
| 19 | 2016 | 19 | |
| 20 | 2023 | 19 |
About Harm Westdorp
Harm Westdorp is a scholar working on Immunology, Oncology, Radiology, Nuclear Medicine and Imaging, Anesthesiology and Pain Medicine and Genetics, having authored 52 papers that have together received 1.3k indexed citations. Recurring topics across this work include Immunotherapy and Immune Responses (13 papers), Cancer Immunotherapy and Biomarkers (8 papers), Radiopharmaceutical Chemistry and Applications (6 papers), Prostate Cancer Treatment and Research (2 papers), BRCA gene mutations in cancer (2 papers), Ocular Oncology and Treatments (1 paper), Cancer survivorship and care (1 paper) and Pancreatic and Hepatic Oncology Research (1 paper). The work is most often cited by research in Immunology (356 citations), Oncology (218 citations), Radiology, Nuclear Medicine and Imaging (150 citations), Ophthalmology (36 citations) and Pulmonary and Respiratory Medicine (74 citations). Harm Westdorp has collaborated with scholars based in Netherlands, Germany and United Kingdom. Frequent co-authors include I. Jolanda M. de Vries, Gerty Schreibelt, Winald R. Gerritsen, Niven Mehra, Sandra Heskamp, Carl Gustav Figdor, James Nagarajah, Bastiaan M. Privé, Nicoline Hoogerbrugge and Willemijn AM van Gemert. Their work appears in journals such as Annals of Oncology, Frontiers in Immunology, Frontiers in Oncology, Clinical Cancer Research and OncoImmunology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.